Zamagni, E; Nanni, C; Gay, F; Pezzi, A; Patriarca, F; Bellò, M; Rambaldi, I; Tacchetti, P; Hillengass, J; Gamberi, B; Pantani, L; Magarotto, V; Versari, A; Offidani, M; Zannetti, B; Carobolante, F; Balma, M; Musto, P; Rensi, M; Mancuso, K; Dimitrakopoulou-Strauss, A; Chauviè, S; Rocchi, Serena; Fard, N; Marzocchi, G; Storto, G; Ghedini, P; Palumbo, A; Fanti, S; Cavo, M, 18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease, «LEUKEMIA», 2016, 30, pp. 417 - 422 [articolo]Open Access
Zannetti, Beatrice Anna; Zamagni, Elena; Santostefano, Marisa; De Sanctis, Lucia Barbara; Tacchetti, Paola; Mancini, Elena; Pantani, Lucia; Brioli, Annamaria; Rizzo, Raffaella; Mancuso, Katia; Rocchi, Serena; Pezzi, Annalisa; Borsi, Enrica; Terragna, Carolina; Marzocchi, Giulia; Santoro, Antonio; Cavo, Michele, Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment, «AMERICAN JOURNAL OF HEMATOLOGY», 2015, 90, pp. 647 - 652 [articolo]
Cavo, M; Pantani, L; Pezzi, A; Petrucci, M T; Patriarca, F; Di Raimondo, F; Marzocchi, G; Galli, M; Montefusco, V; Zamagni, E; Gamberi, B; Tacchetti, P; Brioli, A; Palumbo, A; Sonneveld, P, Bortezomib-thalidomide-dexamethasone (VTD) is superior to bortezomib-cyclophosphamide-dexamethasone (VCD) as induction therapy prior to autologous stem cell transplantation in multiple myeloma, «LEUKEMIA», 2015, 29, pp. 2429 - 2431 [articolo]
Zamagni, Elena; Nanni, Cristina; Mancuso, Katia; Tacchetti, Paola; Pezzi, Annalisa; Pantani, Lucia; Zannetti, Beatrice; Rambaldi, Ilaria; Brioli, Annamaria; Rocchi, Serena; Terragna, Carolina; Martello, Marina; Marzocchi, Giulia; Borsi, Enrica; Rizzello, Ilaria; Fanti, Stefano; Cavo, Michele, PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma, «CLINICAL CANCER RESEARCH», 2015, 21, pp. 4384 - 4390 [articolo]
Musto, Pellegrino; Simeon, Vittorio; Grossi, Alberto; Gay, Francesca; Bringhen, Sara; Larocca, Alessandra; Guariglia, Roberto; Pietrantuono, Giuseppe; Villani, Oreste; D'Arena, Giovanni; Cuomo, Carmela; Musto, Clelia; Morabito, Fortunato; Petrucci, Maria Teresa; Offidani, Massimo; Zamagni, Elena; Tacchetti, Paola; Conticello, Concetta; Milone, Giuseppe; Palumbo, Antonio; Cavo, Michele; Boccadoro, Mario, Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell'Adulto Multiple Myeloma Working Party study, «STEM CELL RESEARCH & THERAPY», 2015, 6, pp. 64 - 64 [articolo]
Palumbo, Antonio; Avet-Loiseau, Hervé; Oliva, Stefania; Lokhorst, Henk M; Goldschmidt, Hartmut; Rosinol, Laura; Richardson, Paul; Caltagirone, Simona; Lahuerta, Juan José; Facon, Thierry; Bringhen, Sara; Gay, Francesca; Attal, Michel; Passera, Roberto; Spencer, Andrew; Offidani, Massimo; Kumar, Shaji; Musto, Pellegrino; Lonial, Sagar; Petrucci, Maria T; Orlowski, Robert Z; Zamagni, Elena; Morgan, Gareth; Dimopoulos, Meletios A; Durie, Brian G M; Anderson, Kenneth C; Sonneveld, Pieter; San Miguel, Jésus; Cavo, Michele; Rajkumar, S Vincent; Moreau, Philippe, Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group, «JOURNAL OF CLINICAL ONCOLOGY», 2015, 33, pp. 2863 - 2869 [articolo]
Dimopoulos, Meletios A; Hillengass, Jens; Usmani, Saad; Zamagni, Elena; Lentzsch, Suzanne; Davies, Faith E; Raje, Noopur; Sezer, Orhan; Zweegman, Sonja; Shah, Jatin; Badros, Ashraf; Shimizu, Kazuyuki; Moreau, Philippe; Chim, Chor-Sang; Lahuerta, Juan José; Hou, Jian; Jurczyszyn, Artur; Goldschmidt, Hartmut; Sonneveld, Pieter; Palumbo, Antonio; Ludwig, Heinz; Cavo, Michele; Barlogie, Bart; Anderson, Kenneth; Roodman, G David; Rajkumar, S Vincent; Durie, Brian G M; Terpos, Evangelos, Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement, «JOURNAL OF CLINICAL ONCOLOGY», 2015, 33, pp. 657 - 664 [articolo]
Brioli, A; Perrone, G; Patriarca, F; Pezzi, A; Nobile, F; Ballerini, F; Motta, M R; Ronconi, S; Tacchetti, P; Catalano, L; Zannetti, B A; Rizzi, S; Volpe, S; Zamagni, E; Liberati, A M; Mancuso, K; Boccadoro, M; Davies, F E; Morgan, G J; Palumbo, A; Cavo, M, Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantation, «BONE MARROW TRANSPLANTATION», 2015, 50, pp. 673 - 678 [articolo]
Patriarca, Francesca; Carobolante, Francesca; Zamagni, Elena; Montefusco, Vittorio; Bruno, Benedetto; Englaro, Emanuaela; Nanni, Cristina; Geatti, Onelio; Isola, Miriam; Sperotto, Alessandra; Buttignol, Silvia; Stocchi, Raffaella; Corradini, Paolo; Cavo, Michele; Fanin, Renato, The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation, «BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION», 2015, 21, pp. 1068 - 1073 [articolo]
Palumbo, A; Cavallo, F; Gay, F; Di Raimondo, F; Ben Yehuda, D; Petrucci, Mt; Pezzatti, S; Caravita, T; Cerrato, C; Ribakovsky, E; Genuardi, M; Cafro, A; Marcatti, M; Catalano, L; Offidani, M; Carella, Am; Zamagni, E; Patriarca, F; Musto, P; Evangelista, A; Ciccone, G; Omedé, P; Crippa, C; Corradini, P; Nagler, A; Boccadoro, M; Cavo, M., Autologous transplantation and maintenance therapy in multiple myeloma., «THE NEW ENGLAND JOURNAL OF MEDICINE», 2014, 371, pp. 895 - 905 [articolo]
Lucia Pantani;Elena Zamagni;Beatrice Anna Zannetti;Annalisa Pezzi;Paola Tacchetti;Annamaria Brioli;Katia Mancuso;Giulia Perrone;Serena Rocchi;Patrizia Tosi;Michele Cavo, Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes, «ANNALS OF HEMATOLOGY», 2014, 93, pp. 123 - 128 [articolo]
Tacchetti, P.; Terragna, C.; Galli, M.; Zamagni, E.; Petrucci, M. T.; Pezzi, A.; Montefusco, V.; Martello, M.; Tosi, P.; Baldini, L.; Peccatori, J.; Ruggieri, M.; Pantani, L.; Lazzaro, A.; Elice, F.; Rocchi, S.; Gozzetti, A.; Cavaletti, G.; Palumbo, A.; Cavo, M., Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study., «AMERICAN JOURNAL OF HEMATOLOGY», 2014, 89, pp. 1085 - 1091 [articolo]
Moreau, P; Cavo, M; Sonneveld, P; Rosinol, L; Attal, M; Pezzi, A; Goldschmidt, H; Lahuerta, Jj; Marit, G; Palumbo, A; van der Holt, B; Bladé, J; Petrucci, Mt; Neben, K; san Miguel, J; Patriarca, F; Lokhorst, H; Zamagni, E; Hulin, C; Gutierrez, N; Facon, T; Caillot, D; Benboubker, L; Harousseau, Jl; Leleu, X; Avet-Loiseau, H; Mary, Jy, Combination of international scoring system 3, high lactate dehydrogenase, and t(4;14) and/or del(17p) identifies patients with multiple myeloma (MM) treated with front-line autologous stem-cell transplantation at high risk of early MM progression-related death., «JOURNAL OF CLINICAL ONCOLOGY», 2014, 32, pp. 2173 - 2180 [articolo]
Enrica Borsi;Giulia Perrone;Carolina Terragna;Marina Martello;Elena Zamagni;Paola Tacchetti;Lucia Pantani;Annamaria Brioli;Angela Flores Dico;Beatrice Anna Zannetti;Serena Rocchi;Michele Cavo, HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment, «EXPERIMENTAL CELL RESEARCH», 2014, 328, pp. 444 - 455 [articolo]
Borsi E;Perrone G;Terragna C;Martello M;Dico AF;Solaini G;Baracca A;Sgarbi G;Pasquinelli G;Valente S;Zamagni E;Tacchetti P;Martinelli G;Cavo M, Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma., «ONCOTARGET», 2014, 5, pp. 1779 - 1792 [articolo]
